Six-week, double-blind, placebo-controlled and long-term, open-label multicenter study of Isoxicam in treatment of degenerative joint disease /

Ejemplares similares

• European double-blind multicenter study comparing Isoxicam and Indomethacin in treatment of degenerative joint disease /
  por: Jessop, John D., et al.
• Six-month double-blind comparison of Isoxicam with buffered Aspirin in rheumatoid arthritis /
  por: Simson, Jerome, et al.
• Evaluation of the safety of Isoxicam /
  por: Burch, Francis X., et al.
• Long-term studies of Isoxicam in the treatment of rheumatoid arthritis /
  por: Reese, Richard W., et al.
• Artrología Canina en 3D Principales Patología Ortopédica y Abordaje Quirúrgicos: /
  por: Climent Peris Salvador
  Publicado: (2014)